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The purpose of this investigation was to study the intra-oral effects of
multiple daily applications ofNaF lozenges upon acid-softened enamel.
Bovine enamel slabs were softened with 0.1 mollL lactate buffer at
pH 4.0 for 14 hrs and subsequently mounted in a mandibular remov-
able Hawley appliance. Control slabs were worn for seven days by
eight adult male subjects who brushed their natural dentition daily
with a fluoride-free dentifrice. Test slabs were exposed to one 0.55-
mg NaF lozenge (0.25 mg F) 4x/day for seven days and the natural
dentition brushed with a fluoride-free dentifrice. The efficacy of 0.25-
mg F lozenges used 4x/day over that ofa 1-mg F lozenge administered
ix/day was established by a pilot study with two subjects. Micro-
hardness testing was performed after intra-oral exposure (IOE) and
following immersion in 0.01 mollL lactate buffer containing Ca and
P04 for 24 hrs at a pH of 4.0. Fluoride uptake was measured on
separate control and test slabs after KOH wash and after acid-resis-
tance-testing (ART). Recovery of microhardness following IOE was
40.9% for controls and 53.9% for treated slabs, while control slabs
retained 1.3% resistance to ART, compared with 25.6% for test slabs.
The F content of the control slabs was significantly less than that of
lozenge-treated and lozenge-treated-ART slabs throughout the depth
of the lesion. The F content of the lozenge-treated-ART slabs was
significantly less than that of the lozenge-treated slabs only at the 0-
5-[Lm depth. The NaF lozenge-treated enamel lesions demonstrated
both significantly greater rehardening and F uptake than did the un-
treated control enamel lesions.
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Introduction.
Dietary fluoride supplements have caused significant anticaries
effects in young children living in fluoride-deficient areas
(Margolis et al., 1975; Marthaler, 1969; Aasenden and Pee-
bles, 1974). Such supplements are marketed commercially as
chewable tablets, lozenges, and swish-and-swallow mouthrin-
ses, which are consumed daily in dosages adjusted to existing
suboptimal fluoride levels in the drinking water. The use of
fluoride supplements causes prolonged elevation of salivary F
levels (Parkins, 1971), an elevation which provides not only
a topical effect to erupted teeth by direct contact with enamel
(Lemke et al., 1970) but also, upon ingestion, incorporation
into the enamel of unerupted teeth (Ahrens, 1976).
As the benefits of fluorides have been more extensively
investigated, it has become increasingly clear that the resultant
reduction in caries is due, in part, to the remineralization of
incipient caries (Koulourides et al., 1974; Gr6n, 1977; Mell-
berg and Ripa, 1983). The process of remineralization appears
to be facilitated by the frequent repetitive use of fluoride agents
of low concentration for prolonged periods (Arends and Gel-
hard, 1983; Ostrom et al., 1984; Featherstone et al., 1982;
Silverstone, 1985), conditions fulfilled by the use of fluoride
lozenges, especially when administered in divided daily doses.
Clark et al. (1986a) demonstrated significant in vivo reharden-
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ing of demineralized enamel following the use of 0.5-mg F
lozenges administered four times daily, but that total dosage
was in excess of the total daily dose recommended for young
children.
It was our purpose to study the intra-oral rehardening of
demineralized bovine enamel with a 0.25-mg F lozenge used
four times daily, which represents the total daily dose rec-
ommended by the Council on Dental Therapeutics of the
American Dental Association (Accepted Dental Therapeutics,
1984) for children three years of age or older and living in
fluoride-free areas.
Materials and methods.
Enamel slabs (3 X 3 x 2 mm) were cut from the labial
surfaces of bovine permanent incisors and mounted on acrylic
disks by means of sticky wax. Using a paralleling device, we
removed approximately 50 to 100 pm of the surface enamel
by polishing to a smooth flat surface with wet emery paper
(240-, 400-, and 600-mesh) (Koulourides et al., 1976).
Following exposure to 1% ethylene oxide vapor for eight
hrs, each slab was demineralized by exposure to 20 mL of 0.1
mol/L lactic acid for 14 hrs at 37TC. The acid solution con-
tained 1% sodium carboxymethylcellulose with 3 mmol/L cal-
cium and 1.8 mmol/L phosphate and the pH adjusted to 4.0.
Removable mandibular acrylic appliances were fabricated
for eight healthy male subjects, ages from 25 to 55 yrs (Zim-
mermann et al., 1985). Recesses large enough to accommodate
up to 16 slabs each were cut into the right and left sides of
each appliance. Sixteen pre-softened slabs were mounted lin-
gually on each side of the appliance, with sticky wax used to
seal the lateral borders of the slabs and create a smooth contour
for comfort while the appliance was being worn. Thirty-two
control slabs were worn for seven days by each subject, 16 of
which were used for microhardness-testing and 16 for fluoride
analysis. Thirty-two slabs were used initially for the experi-
mental phase with NaF lozenges (16 for microhardness, 16 for
fluoride uptake). An additional 16 slabs were treated with the
same NaF lozenge regimen, and those slabs were subsequently
subjected to in vitro acid exposure prior to analysis for F con-
tent. The location of individual slabs in the appliance was
recorded for each subject in all phases of the experiment so
that we could determine site-to-site variations. The appliance
was worn continuously by each test subject except at meal-
times. All subjects gently cleansed the enamel slabs with
moistened cotton swabs and brushed the natural dentition with
a fluoride-free dentifrice (Pepsodent, Lever Brothers Co., NY)
4x/day during both control and experimental periods.
Each subject ingested a single 0.55-mg NaF (0.25 mg F)
lozenge (Luride Lozi Tabs, Hoyt Laboratories, Needham, MA)
4x/day during the seven-day experimental phase. The lozenge
was placed on the tongue and dissolved slowly in the saliva
which was swished and ultimately swallowed. The ingestion
of each lozenge followed the four daily brushings (i.e., fol-
lowing regular meals and at bedtime) for seven consecutive
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days. All slabs were worn for approximately eight hrs after
the last lozenge was administered.
A Tukon Microhardness Tester (Wilson Instrument Divi-
sion, Bridgeport, CT) with a pyramidal diamond indenter and
a 500-g load was used to determine microhardness values of
all slabs at four different times: (1) prior to acid-softening, (2)
following acid-softening, (3) following intra-oral exposure (1OE),
and (4) following acid-resistance-testing (ART). Each prior set
of measurements was re-measured for assurance that no changes
in lengths of previous indentations had occurred.
Acid-resistance-testing was performed by immersion of each
slab in 20 mL of 0.01 mol/L lactic acid-sodium hydroxide
buffer (pH 4.0), containing 1% sodium carboxymethylcellu-
lose with 3 mmol/L calcium and 1.8 mmol/L phosphate, at
370C for 24 hrs. The percentage changes in microhardness
following both IOE and ART were calculated by the method
described by Gelhard et al. (1979). Paired t tests were per-
formed so that we could test differences in JOE and ART
values between control and test slabs.
Prior to the initiation of the present study, we performed a
pilot study to compare the effects of a 1-mg F lozenge used
Ix/day with those of the same total amount (1 mg F) applied
in four equally divided doses (0.25 mg F) for a period of seven
consecutive days. Two subjects (A and B), who demonstrated
in previous studies their consistent ability for intra-oral rehar-
dening of demineralized bovine enamel (Corpron et al., 1986a;
Clark et al., 1986a; Clark et al., 1986b), wore 16 acid-softened
bovine enamel slabs for each period for controls, 1-mg F loz-
enges used ix/day, and 0.25-mg F lozenges used 4x/day for
seven consecutive days, as described in previous paragraphs.
Microhardness-testing was performed and IOE% and ART%
calculated for determination of the more effective experimental
regimen to be subsequently utilized in the expanded study us-
ing the eight subjects.
Those slabs to be analyzed for fluoride content following
intra-oral exposure were removed from the appliance, cleansed
with a cotton swab and distilled water, and glued on the end
of a plastic rod (0.64 cm in diameter). The lateral borders were
sealed with blue inlay wax, and the slabs were immersed in
0.5 mL of 1.0 mol/L KOH for 24 hrs at room temperature so
that the alkali-soluble fluoride would be removed from the
surface (Caslavska et al., 1975). These vials were retained for
fluoride analysis of the KOH wash, to which 0.5 mL of 1 mol/
L HNO3 and 0.5 mL of modified TISAB II were added prior
to fluoride analysis (deBruyn et al., 1985). Sixteen additional
experimental slabs were immersed for 24 hrs in KOH follow-
ing IOE and subsequently exposed to in vitro acid-resistance-
testing prior to fluoride analysis.
Five layers were removed from the 3 x 3 mm enamel sur-
face by being immersed in separate vials containing 1.0 mL
of 0.5 mol/L perchloric acid for 15, 30, 30, 60, and 60 sec.
The specimens were rotated at 100 rpm for a standard agita-
tion. The slabs were rinsed with 1 mL of total ionic strength
adjusted buffer (modified TISAB II), and dried with a cotton
pellet which was added to the vial after each etch. The mod-
ified TISAB II (CDTA, Orion Research, Inc., Cambridge,
MA) was prepared by combining 100 mL of TISAB II with
15 mL of I molIL NaOH at pH of 5.6. The fluoride concen-
tration was determined directly by means of an Orion Ion Ana-
lyzer 901 (Orion Research, Inc., Cambridge, MA) equipped
with a fluoride-ion specific electrode (Orion 96-09). The 901
Analyzer was first calibrated with standard fluoride solutions
diluted with TISAB II to the same dilution factor as that of
the unknown samples. Phosphate concentrations were deter-
mined by spectrophotometry by means of the method of Gee
et al. (1954).
The depth of enamel removed by each etch was calculated
from the etched area of enamel (3 x 3 mm) and the amount
of phosphate in the aliquots. The phosphate content of bovine
enamel was assumed to be 51.2% and the mineral density 2.88
g/cm (Davidson et al., 1976). This density value, and therefore
the calculations, were approximations, since the density after
partial intra-oral remineralization was not known. However,
this procedure provided a convenient means of presenting the
F levels in enamel, assuming that the error in enamel density
was similar in both regimens.
In order to describe the overall relationship between the
depth (jim) and the fluoride content (ppm) for control, F-loz-
enge-treated, and F-lozenge-ART-treated slabs, we calculated
the X ± SEM for F content and recorded it in ppm for the
approximate midpoint of 5-jim intervals from 0-50 jim and of
10-jim intervals from 50-100 jLim from the enamel surface. In
order to describe the relationship of the F uptake to depth (>im)
of enamel for controls and each set of test slabs, we used the
analysis of variance for differences in mean F content among
the three sets of slabs for each depth. Modified t tests incor-
porating Bonferroni's correction were used to compare each
pair of means when the overall analysis of variance proved
significant. Pearson's product-moment correlation coefficient
was used to examine relationships between IOE and ART val-
ues and between control and treated specimens.
Results.
Microhardness.-Values for X + SD for the two subjects
(A and B) involved in the pilot study for the IOE% and ART%
were 52.52 ± 4.18 and 28.28 + 4.74, respectively, for the
1-mg F lozenge ingested ix/day, as compared with 62.35 +
0.26 and 33.82 + 2.78 for the respective IOE% and ART%
values when the 0.25-mg F lozenges were used 4x/day. The
values for the regimen utilizing the divided dosages were sig-
nificantly higher (p < 0.05) than respective values for the
single 1-mg F lozenge. Such differences provided the basis for
using the divided doses for the expanded study using the eight
subjects.
Values for X + SD for the eight subjects (A-H) for depth
of penetration (jim) of the microhardness indenter are shown
for control (Table 1) and F-treated slabs (Table 2). These val-
ues include the microhardness measurements following: (a)
abrasion and polishing, (b) acid-softening, (c) post-JOE, and
(d) post-ART. The percentage changes in microhardness ap-
pear in Table 3.
The measurement of prior indentations revealed no changes
in length of indentation, indicating that the integrity of the
surface layer was maintained throughout acid-softening, IOE,
and ART procedures.
TABLE 1
MICROHARDNESS VALUES FOR CONTROL GROUP
(depth of indenter penetration in Vtm)
Sound Post- Post- Post-
Subject Enamel softened IOE ART
A 5.56 17.31 11.55 15.80
B 5.48 14.46 10.02 14.16
C 5.51 16.47 11.15 15.71
D 5.50 13.35 10.67 14.22
E 5.48 14.01 11.25 14.10
F 5.50 17.85 12.43 15.86
G 5.47 18.35 13.71 20.12
H 5.58 14.70 11.62 14.95
X 5.51 15.81 11.55 15.62
(-+ SD) (±0.04) (+ 1.79) (+ 1.05) (+ 1.84)
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TABLE 2
MICROHARDNESS VALUES FOR EXPERIMENTAL GROUP
(depth of indenter penetration in pum)
Sound Post- Post- Post-
Subject Enamel softened IOE ART
A 5.52 17.35 10.01 13.02
B 5.50 18.08 11.29 14.11
C 5.50 15.26 9.15 12.23
D 5.54 15.32 8.98 12.38
E 5.50 17.67 10.27 14.20
F 5.46 17.62 11.70 14.74
G 5.56 17.39 13.57 15.79
H 5.49 15.33 10.80 14.41
X 5.51 16.75 10.72 13.86
(± SD) (±0.03) (±1.14) (+1.40) (+1.15)
TABLE 3
REHARDENING VALUES (PERCENTAGE RECOVERY)
(listed by descending Lozenge-ART values)
Seven-day Lozenge Seven-day Control
Subject Post- Post- Post- Post-
(N = 8) IOE ART IOE ART
A 62.09 36.60 49.00 12.84
B 53.99 31.58 49.44 3.34
C 62.60 31.04 48.54 6.93
D 64.79 30.08 34.10 -11.12
E 60.81 28.51 32.36 -1.06
F 48.69 23.68 43.89 16.11
G 32.28 13.55 36.08 -13.76
H 46.05 9.38 33.73 -2.72
X 53.91 25.55*1 40.89 1.32
(±+ SD) (±11.12) (±9.46) (±7.56) (±10.63)
*Significant difference from controls (p<0.05).
L Significant difference between JOE and ART (p<0.S).
The lozenge-treated slabs developed a significantly higher
rehardening (53.9%) following LOE, compared with controls
(40.9%, p<0.05). More significantly, the lozenge-treated slabs
retained approximately one-half of their rehardening (25.6%)
following ART compared with controls, which lost virtually
all of their rehardening (1.3%) following ART (p<005).
A direct correlation was found between the mean values for
%IOE and %ART for lozenge-treated slabs (r = 0.72) and
between control %IOE and %ART values (r = 0.82). Con-
versely, there was no significant correlation between the con-
trol and treatment ART values, nor between control and treatment
IOE values.
There was no consistent site-to-site variation of microhard-
ness of slabs in any of the subjects.
Fluoride uptake. The mean values and standard error of
the means (SEM) for F content of control and lozenge-treated
slabs are shown in the Fig.
There was a significant difference (p<0.05 using Bonfer-
roni's correction) in fluoride content between control and both
test groups when the three groups were compared by analysis
of variance at each depth. Pairwise Student's t tests demon-
strated that a significant difference (p<0.05 using Bonferroni's
correction) in fluoride content existed at all depths of enamel
when the control slabs were compared separately with each of
the experimentally treated slabs.
In comparing the two groups of experimentally treated slabs,
we found that there was no consistent difference (p>0.05 using
Bonferroni's correction) in fluoride content between the slabs
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Fig. - Fluoride concentration (ppm) vs. depth (Scm) from the enamel
surface. Control (O-O); Lozenge - KOH (0 ---- 0); Lozenge KOH-
ART (O - - - * - 0). SEM (T())
except at the most superficial depth considered (i.e., from 0
to 5 jirm).
Similar to the absence of site-to-site variation in the micro-
hardness values, there was no consistent site-to-site variation
in fluoride uptake.
The mean values for the alkali-soluble F content of the KOH
washes were 0.31 + 0.18 jig/cm for the control slabs and
0.83 ± 0.54 jig/cm for the treated slabs.
Discussion.
There exists considerable clinical evidence of anticaries ef-
fects following the consumption of dietary F supplements (Bibby
et al., 1955; Arnold et al., 1960; DePaola and Lax, 1968;
Marthaler, 1969; Hennon et al., 1967; Aasenden and Peebles,
1974; Driscoll et al., 1977; Margolis et al., 1975), but the
cariostatic mechanisms involved are not completely under-
stood. There is general agreement that the ingestion of fluoride
supplements leads to incorporation of fluoride ions into de-
veloping enamel (Ahrens, 1976), and supplements such as
fluoride lozenges, designed to dissolve slowly in the oral cav-
ity, cause elevated salivary F levels (Parkins, 1971; Graf and
Miihlemann, 1969; McCall et al., 1981), providing a topical
effect upon the enamel surfaces of erupted teeth (Torell, 1965;
Lemke et al., 1970). This effect by topical fluoride agents
during the post-eruptive period has led investigators to con-
clude that the resultant reduction in decay was due, in part, to
the remineralization of existing incipient enamel caries (Kou-
lourides et al., 1976; Gr6n, 1977; Mellberg and Ripa, 1983).
Enamel remineralization is considered to be a natural phe-
nomenon which depends upon the degree of saturation of saliva
with respect to fluorapatite (FAP) and/or hydroxyapatite (HAP)
(Ericsson, 1949; McCann, 1968). The degree of saturation
depends upon the pH and the concentration of calcium, phos-
phate, and fluoride ions in the saliva, and it appears that low
levels of fluoride in saliva can effectively stimulate reminer-
alization (Arends and Gelhard, 1983; Featherstone, 1983). On
the other hand, high fluoride levels (i.e., 1.23% APF) cause
formation of CaF2 on the surface of the enamel (Larsen et al.,
1981), which can initially block or retard remineralization (Bodde
and Arends, 1980). Remineralization, therefore, appears to be
promoted by the frequent, repetitive use of topical agents con-
taining low levels of fluoride used for prolonged periods, the
concept which influenced the design of the current study.
Since it is desirable for children who live in fluoride-defi-
cient areas to be provided with the same cariostatic benefits
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attained by those living in fluoridated areas (Arnold et al.,
1960; Aasenden and Peebles, 1974; Margolis et al., 1975),
dietary F supplements in the form of lozenges offer the poten-
tial of both protection for developing teeth and remineralization
of incipient enamel lesions in erupted teeth. It was previously
demonstrated that F lozenges (0.50 mg F administered 4x/day)
could cause significant rehardening in demineralized enamel
in adults (Clark et al., 1986a), but the total dose of 2 mg F!
day is excessive in children. In this study, the use of 1 mg F/
day in four equally divided doses provided repetitive, frequent,
low doses which could be effective in both children and adults
without exceeding the maximum daily dose for children. Ad-
ditionally, the slow dissolution of the lozenge should prolong
the direct exposure of the enamel surface to the elevated sal-
ivary F levels (McCall et al., 1981; Graf and Miihlemann,
1969). The results of rehardening due to the use of a single 1-
mg lozenge lxlday, compared with the same amount admin-
istered in four equally divided daily doses (0.25 mg F), ob-
tained in the pilot portion of this study supported the concept
of the greater efficacy of frequent divided daily doses, com-
pared with that of the same total dose applied at one time, in
the remineralization of demineralized enamel.
The results of this study provide additional information re-
garding the mechanisms of rehardening of demineralized enamel
by means of F lozenges, but the results obtained on pre-soft-
ened bovine enamel in a removable appliance cannot be di-
rectly equated with those benefits which would be received by
natural white-spot lesions in human teeth.
Following intra-oral exposure to the F lozenge, KOH washes
were used to ensure the removal of alkali-soluble F (i.e., CaF2)
which might have formed on the surface of the enamel (Cas-
lavska et al., 1975). When the KOH washes from test slabs
were analyzed for F, no appreciable amount was found, dem-
onstrating that deposition of CaF2 was not a factor in the re-
hardening following the dissolution of the F lozenge. The
significantly greater microhardness and increased F content in
the treated enamel slabs after IOE, as compared with those of
controls, illustrate that the differences were caused by in-
creased deposition of stable F compounds, such as FAP and/
or FHAP (Hercules and Craig, 1968). These mineral com-
pounds provided significant protection to the enamel from the
in vitro acid exposure (Table 3). It appears that only the out-
ermost portion of the surface layer (from 0 to 5 [tm) experi-
enced significant loss of F following ART, demonstrating that
the outer F-rich surface layer protected the deeper areas of the
lesion from acid attack. Conversely, the control slabs re-soft-
ened after ART to almost the original post-softening values
(Table 3), due to the uniformly low levels of F throughout the
depth of the lesion (Fig.).
The variability of rehardening of enamel lesions in our sub-
jects (Table 3) supports similar observations by Featherstone
et al. (1982) and the findings of our previous studies using
other topical F agents (Corpron et al., 1986a; Clark et al.,
1986a). However, there appeared to be some consistency for
each individual's ability to reharden enamel lesions and the
ability of the newly rehardened lesions to resist subsequent
acid attack (ART).
Weatherell et al. (1984) studied the migration. of fluoride in
the oral cavity following the dissolution of a 1-mg F tablet
placed asymmetrically in the mandibular buccal sulcus. Their
analyses indicated that relatively little transfer from the site of
dissolution occurred to the opposite side of the mouth. In an
additional study using a F mouthrinse, Weatherell et al. (1986)
observed a rapid clearance of F from beneath the tongue fol-
lowing the use of the mouthrinse. In the present study, we
observed no consistent site-to-site variation in rehardening,
suggesting that the slow dissolution of the lozenge on the dor-
sal or ventral surface of the tongue allowed for prolonged con-
tact of the salivary F with the sublingually placed enamel slabs,
especially since the subjects were encouraged to recirculate the
saliva instead of swallowing immediately during dissolution of
the lozenge.
Although currently not widely advocated, the use of divided
doses of dietary F lozenges appears to fulfill the requirements
for remineralizing action of the lozenges. Dividing the daily
dose into four lozenges each containing 0.25 mg F means more
frequent application of a smaller dose than the normal appli-
cation of the individual 1.0-mg F lozenge once per day. Com-
pliance of the divided doses could easily become a problem
over extended periods, possibly limiting the use of divided
doses to the periods of peak caries activity or for special pa-
tients.
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